Publications
- Which findings may predict resectability of the patients with lung cancer?Publication without faculty affiliation
- Case reports of patients with ALK-positive NSCLC and brain metastases2023 | First Faculty of Medicine
- Současné místo trastuzumab deruxtecanu v léčbě karcinomu žaludku a gastroezofageální junkce2023 | First Faculty of Medicine
- Treatment of lung cancer with targetable mutations - new drugs and indications2023 | First Faculty of Medicine
- Malignant pleural mesothelioma – case report2023 | First Faculty of Medicine
- Adjuvantní léčba anti-EGFR tyrosinkinázovými inhibitory u resekovaného NSCLC a studie ADAURA – komentář2023 | First Faculty of Medicine
- Targeted treatment and immunotherapy of advanced non-small cell lung cancer2022 | First Faculty of Medicine
- Osimertinib in treating advanced non-squamous non-small cell lung cancer2022 | First Faculty of Medicine
- Imunoterapie u pacientky s malobuněčným plicním karcinomem2022 | First Faculty of Medicine
- Pokroky v systémové léčbě nádorů žaludku se zaměřením na imunoterapii a molekulárně cílenou léčbu2022 | First Faculty of Medicine
Loading network view...